Response to Alcohol and HBV-related hepatocellular carcinoma: the unmeasured role of antiviral therapy
Clinical Gastroenterology and Hepatology · 2026-10
DOI: 10.1016/j.cgh.2026.10.014 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-10. Verfasst von Yukai Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional and Western Medical Hepatology, Hebei Medical University Third Hospital, Shijiazhuang, Hebei Province 050051, China; Depart….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Traditional and Western Medical Hepatology, Hebei Medical University Third Hospital, Shijiazhuang, Hebei Province 050051, China; Department of Gastroenterology, Hebei Medical University Third Hospital, Shi…
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, China; Institute of Viruses and Infectious Diseases, Nanjing U…
Zitieren
APA
Chen, Y., Rui, F., Li, J., & Nan, Y. (2026). Response to Alcohol and HBV-related hepatocellular carcinoma: the unmeasured role of antiviral therapy. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.10.014
Vancouver
Chen Y, Rui F, Li J, Nan Y. Response to Alcohol and HBV-related hepatocellular carcinoma: the unmeasured role of antiviral therapy. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.10.014
BibTeX
@article{Chen2026,
author = {Chen, Yukai and Rui, Fajuan and Li, Jie and Nan, Yuemin},
title = {Response to Alcohol and HBV-related hepatocellular carcinoma: the unmeasured role of antiviral therapy},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.10.014}
}
EUVIMED